Prevalence and evolution of heart failure in patients with type 2 diabetes mellitus at high cardiovascular risk (HF-LANDMARK study).
The low prevalence of symptomatic HF and low rate of HF-progression likely reflect effective monitoring and intervention at preclinical HF stages, and the substantial healthcare-burden highlights an unmet need regarding implementation of HF preventive management strategies in patients with T2D.